May 2026 in “Journal of Skin and Sexually Transmitted Diseases” This review highlights the demonstrated efficacy and growing use of upadacitinib for cutaneous disorders, emphasizing its cost-effectiveness and recent availability in India compared to other biologics and small-molecule therapies, rather than providing new primary data.
May 2026 in “Ukrainian journal of veterinary sciences” In this study, researchers found that parasitic dermatitis in dogs is predominantly caused by ectoparasites like fleas and mites, with flea allergy dermatitis being particularly prevalent, and noted that diagnosis typically relies on laboratory methods, while treatments involve insectoacaricidal drugs and prevention strategies.
May 2026 in “Journal of Wildlife and Conservation Medicine” This study found that camera trap images revealed mange-like skin lesions in snow leopards and other species in Kyrgyz reserves, with detection rates varying widely and raising concerns about disease spread.
May 2026 in “International Journal of Advanced Biochemistry Research” In this case study, a three-year-old Labrador with canine atopic dermatitis showed significant improvement in pruritus and skin lesions after treatment with oclacitinib and supportive therapy over a one-month follow-up.
April 2026 in “Frontiers in Medicine” In this case report, a female patient with both psoriasis and lichen planus initially responded to acitretin and topical mometasone but experienced a relapse after stopping the treatment. The authors reported marked improvement within 3 months after switching to upadacitinib, aiming to guide clinical decision-making.
April 2026 in “Dermatology and Therapy” This study reviews the efficacy and safety of advanced therapies like TNFα inhibitors and IL-17/IL-23 inhibitors for dissecting cellulitis of the scalp, finding TNFα inhibitors particularly effective for severe or refractory cases, although prospective validation is needed for early intervention benefits.
March 2026 in “Frontiers in Medicine” This study reviews advances in targeted therapies for moderate-severe dermatological conditions like plaque psoriasis and atopic dermatitis, reporting on newly approved treatments and highlighting the need for further innovations in managing rare inflammatory skin diseases through emerging laboratory techniques and trials.
March 2026 in “IP Indian Journal of Clinical and Experimental Dermatology” Among elderly individuals attending a dermatology department, this study found that common skin conditions were wrinkles, xerosis, and seborrheic keratosis, with infections and eczema being the most frequent pathological conditions, highlighting the need for public health measures targeting geriatric dermatoses.
March 2026 in “Buletin Veteriner Udayana” In this study, dogs with atopic dermatitis showed significant improvements in macroscopic skin lesions, such as reduced pruritus and hair regrowth, after receiving coconut oil massages every three days for 33 days.
This source provides medical information intended solely for licensed professionals and emphasizes that it is not a substitute for medical advice, diagnosis, or treatment decisions, which remain the responsibility of treating physicians.
January 2026 in “Forum Dermatologicum” This study observed that 2.5% of patients with mycosis fungoides or Szary syndrome experienced alopecia, predominantly within skin lesions, with scalp metastases from other cancers also potentially causing hair loss, highlighting the diagnostic value of trichoscopy in differentiating alopecia types.
January 2026 in “International Journal of Advanced Biochemistry Research” This case report describes a 4-year-old dog successfully managed for primary hypothyroidism and concurrent Babesia gibsoni infection, treated with thyroxine, Diminazine aceturate, antibiotics, and supportive therapies, resulting in clinical improvement and negative blood smear for Babesia by day 30.
November 2025 in “Frontiers in Medicine” In this prospective cohort, baseline severity, disease activity, and relapse history were identified as key factors influencing response and recurrence in alopecia areata, suggesting that implementing standardized assessments could enhance risk stratification and personalized care approaches.
November 2025 in “Clinical Cosmetic and Investigational Dermatology” In this case study, a 46-year-old woman with tattoos and a history of hypothyroidism developed autoimmune-like symptoms, highlighting the importance of distinguishing ASIA syndrome from other immune disorders and assessing potential adjuvant exposure.
October 2025 in “Dermatology and Therapy” This study investigates the complex impact of bariatric surgery on skin disorders, reporting improvements in conditions like acanthosis nigricans and psoriasis, while new issues such as xeroderma and alopecia may also emerge postoperatively.
September 2025 in “Cureus” This review suggests that GLP-1 receptor agonists may improve various dermatologic conditions, but larger studies are needed to confirm these findings.
February 2025 in “Cureus” In this case report, a 31-year-old man developed erosive pustular dermatosis of the scalp after hair transplant surgery, highlighting potential surgical trauma as a trigger for this condition in younger patients.
February 2025 in “Frontiers in Veterinary Science” This case report highlights the successful use of Prussian Blue to treat a dog suffering from thallium intoxication, demonstrating the importance of early diagnosis and targeted therapy in veterinary care for improving recovery outcomes.
January 2025 in “International Journal of Biology Sciences” In this case study, a 10-month-old Doberman with generalized demodicosis recovered fully after treatment with a combination of systemic and topical therapies, including ivermectin, hydroxyzine, enrofloxacin, fluralaner, and specialized shampoos.
January 2025 in “Dermatology Review” This paper outlines the clinical features of artefactual skin disorder, emphasizing the complexities in diagnosing the self-inflicted lesions that patients deny, and underscores the importance of integrating dermatological, psychiatric, and psychological treatment approaches.
January 2025 in “International Journal of Veterinary Sciences and Animal Husbandry” In this case study, researchers found that treatment with sarolaner led to complete recovery from generalized demodicosis in six dogs within four weeks, resolving clinical signs without adverse reactions.
January 2025 in “International Journal of Advanced Biochemistry Research” This research proposes to investigate the incidence of skin diseases in dogs from North-eastern India linked to deficiencies in alpha-linolenic and linoleic acids, as these essential fatty acids have anti-inflammatory and immunomodulatory benefits potentially aiding inflammatory skin disease therapy.
January 2025 in “The Atlantic Journal of Medical Science and Research” This study observed that anxiety and depression affect 21.7% and 38.7% of dermatology outpatients, respectively, with higher prevalence linked to demographics like female gender for anxiety, being single, unemployed, and having lower education, and specific conditions such as psoriasis and acne.
January 2025 in “International Journal of Advanced Biochemistry Research” In this study, dogs diagnosed with demodicosis achieved full recovery after a single dose of fluralaner, with clinical improvement supported by negative skin scraping results by day 28, and hematobiochemical parameters normalizing over the treatment period.
December 2024 in “Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi” This study found that switching patients with alopecia areata unresponsive to topical clobetasol 17 propionate 0.05% to anthralin treatment led to improved treatment success.
May 2024 in “Journal of Education, Health and Sport” This review article highlights the complexity of treating folliculitis decalvans, emphasizing the role of systemic antibiotics like rifampicin and clindamycin as common treatments, while also discussing promising novel therapies, including biological agents, that require further clinical trials to assess their effectiveness and safety.
April 2024 in “Exploratory Animal and Medical Research” This study describes how dogs can suffer from dermatological issues due to arthropod parasites, notably mange caused by Sarcoptes mites, which leads to skin irritation, hair loss, and can escalate to severe conditions if untreated.
March 2024 in “Journal of Rawalpindi Medical College/Journal Rawalpindi Medical College” This study observed that skin conditions like hirsutism, acne, and androgenic alopecia were common in PCOS patients and may aid in its diagnosis.
January 2024 in “Jurnal Ilmu Kesehatan Hewan” In this veterinary case report, a mixed breed dog with Malassezia dermatitis showed significant improvement and hair regrowth after 28 days of treatment with ketoconazole and other supportive therapies.
January 2024 in “International journal of advanced biochemistry research” This case study reported that a one-year-old male dog with demodicosis successfully recovered after treatment with Bravecto (fluralaner) and supportive therapies, highlighting the importance of recognizing and managing Demodex canis infections in dogs.